COM:MILESTONEPHARMA
Milestone Pharmaceuticals, Inc.
- Stock
Last Close
1.85
22/11 21:00
Market Cap
98.12M
Beta: -
Volume Today
276.50K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | -289K - | -651.50K 125.43% | -540.50K 17.04% | -343.50K 36.45% | -165.50K 51.82% | |||
average payables | 1.71M - | 3.49M 103.95% | 4.51M 29.20% | 4.51M 0.09% | 3.32M 26.35% | 3.12M 6.06% | ||
average receivables | 610K - | 756.50K 24.02% | 892K 17.91% | 715.50K 19.79% | 848K 18.52% | 2.53M 198.58% | ||
book value per share | -1.40 - | -2.33 66.70% | 7.28 411.83% | 4.88 33.01% | 2.69 44.81% | 1.56 41.93% | 0.39 75.02% | |
capex per share | -0.00 - | -0.00 86.11% | -0.03 12,274.54% | -0.01 - | -0.00 59.31% | |||
capex to depreciation | -4.50 - | -0.50 88.89% | -10.87 2,073.68% | -3.06 - | -0.19 93.87% | |||
capex to operating cash flow | 0.00 - | 0.00 94.69% | 0.01 3,298.50% | 0.01 - | 0.00 53.46% | |||
capex to revenue | -0.05 - | -0.11 105.88% | ||||||
cash per share | 1.14 - | 3.64 219.47% | 7.59 108.78% | 4.85 36.11% | 2.73 43.74% | 1.52 44.24% | 1.54 0.99% | |
days of inventory on hand | ||||||||
days payables outstanding | 2.43K - | |||||||
days sales outstanding | 11.75 - | 88.55 653.42% | 1.41K 1,487.39% | |||||
debt to assets | 0.00 - | 0.01 50.67% | 0.01 7.18% | 0.03 474.24% | 0.67 1,900.04% | |||
debt to equity | 0.00 - | 0.01 47.00% | 0.01 5.72% | 0.04 505.66% | 3.00 7,891.32% | |||
dividend yield | ||||||||
earnings yield | -0.02 - | -0.06 186.73% | -0.22 242.60% | -0.25 16.29% | -0.16 38.78% | -0.34 118.44% | -0.83 144.80% | |
enterprise value | 352.58M - | 277.52M 21.29% | 133.41M 51.93% | 125.24M 6.12% | 160.57M 28.21% | 162.96M 1.49% | 109.75M 32.65% | |
enterprise value over ebitda | -42.69 - | -11.65 72.70% | -2.31 80.21% | -2.47 7.29% | -3.74 50.98% | -2.73 26.86% | -1.80 33.95% | |
ev to operating cash flow | -43.79 - | -13.19 69.89% | -2.61 80.22% | -2.47 5.34% | -4.83 95.77% | -3.11 35.74% | -2.36 23.88% | |
ev to sales | 10.70 - | 32.59 204.46% | 109.75 236.75% | |||||
free cash flow per share | -0.34 - | -0.89 160.27% | -3.27 266.97% | -1.73 47.08% | -0.79 54.06% | -1.24 56.44% | -1.08 12.80% | |
free cash flow yield | -0.02 - | -0.06 160.27% | -0.20 252.30% | -0.26 26.46% | -0.12 53.01% | -0.31 158.76% | -0.65 106.77% | |
graham net net | -1.41 - | -2.40 70.13% | 7.07 394.43% | 4.63 34.57% | 2.56 44.69% | 1.35 47.36% | 0.24 81.97% | |
graham number | 3.28 - | 7.18 118.63% | 23.94 233.59% | 13.67 42.90% | 7.86 42.53% | 6.88 12.43% | 3.49 49.22% | |
income quality | 1.00 - | 0.91 8.84% | 0.93 2.03% | 1.02 9.62% | 0.78 23.64% | 0.90 15.91% | 0.78 13.44% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -22.30 - | -69.85 213.27% | 47.56 - | -24.04 150.55% | ||||
interest debt per share | 0.20 - | 0.06 71.17% | 0.02 70.63% | 0.03 74.65% | 1.23 4,123.92% | |||
inventory turnover | ||||||||
invested capital | 0.00 - | 0.01 47.00% | 0.01 5.72% | 0.04 505.66% | 3.00 7,891.32% | |||
market cap | 363.46M - | 363.46M 0% | 252.71M 30.47% | 196.61M 22.20% | 274.01M 39.37% | 168.10M 38.65% | 71.74M 57.33% | |
net current asset value | -33.15M - | -55.24M 66.62% | 113.99M 306.35% | 141.83M 24.43% | 111.67M 21.26% | 63.67M 42.99% | 14.58M 77.10% | |
net debt to ebitda | 1.32 - | 3.61 174.02% | 2.06 42.86% | 1.41 31.63% | 2.64 87.18% | 0.09 96.73% | -0.63 824.66% | |
net income per share | -0.34 - | -0.98 186.73% | -3.50 256.87% | -1.70 51.33% | -1.02 40.15% | -1.35 32.07% | -1.39 3.24% | |
operating cash flow per share | -0.34 - | -0.89 161.38% | -3.24 264.12% | -1.73 46.65% | -0.79 54.06% | -1.24 55.63% | -1.08 12.56% | |
payables turnover | 0.15 - | |||||||
receivables turnover | 31.06 - | 4.12 86.73% | 0.26 93.70% | |||||
research and ddevelopement to revenue | 2.58 - | 7.97 208.98% | 31.27 292.58% | |||||
return on tangible assets | -0.29 - | -0.26 10.19% | -0.45 69.99% | -0.33 25.54% | -0.36 6.77% | -0.77 115.64% | -0.79 3.43% | |
revenue per share | 0.36 - | 0.12 67.15% | 0.02 80.24% | |||||
roe | 0.24 - | 0.42 72.00% | -0.48 214.44% | -0.35 27.36% | -0.38 8.45% | -0.86 127.44% | -3.56 313.28% | |
roic | 0.25 - | 0.43 73.30% | -0.50 215.21% | -0.35 29.90% | -0.38 7.52% | -0.82 117.66% | -0.89 8.93% | |
sales general and administrative to revenue | 0.83 - | 3.14 280.30% | 15.93 406.81% | |||||
shareholders equity per share | -1.40 - | -2.33 66.70% | 7.28 411.83% | 4.88 33.01% | 2.69 44.81% | 1.56 41.93% | 0.39 75.02% | |
stock based compensation to revenue | 0.49 - | 1.81 272.91% | 9.53 426.86% | |||||
tangible asset value | -33.12M - | -55.21M 66.70% | 114.92M 308.15% | 143.12M 24.54% | 112.60M 21.32% | 66.35M 41.08% | 16.77M 74.72% | |
tangible book value per share | -1.40 - | -2.33 66.70% | 7.28 411.83% | 4.88 33.01% | 2.69 44.81% | 1.56 41.93% | 0.39 75.02% | |
working capital | 25.95M - | 83.52M 221.84% | 114.17M 36.70% | 142.53M 24.84% | 112.15M 21.31% | 65.66M 41.45% | 65.81M 0.22% |
All numbers in (except ratios and percentages)